The University of California San Francisco Brain Metastases Stereotactic Radiosurgery (UCSF-BMSR) MRI Dataset
0
💬
Sign in to get full access
Overview
- This dataset consists of 560 brain MRI scans from 412 patients with brain metastases.
- The scans include registered and skull-stripped T1 post-contrast, T1 pre-contrast, FLAIR, and subtraction images.
- The dataset also includes voxel-wise segmentations of the brain metastases, patient demographics, surgical status, and primary cancer types.
- The dataset has been made publicly available to help advance AI applications for brain metastases.
Plain English Explanation
This dataset contains a large collection of brain MRI scans from patients with brain metastases, which are tumors that have spread to the brain from cancer in another part of the body. The scans include different types of MRI images, like ones taken before and after contrast dye is injected, as well as specialized images that highlight certain features. Experts have also carefully labeled the exact location and size of the brain metastases in the scans.
The dataset provides a rich resource for researchers working on brain tumor segmentation and other AI applications for brain metastases. By making this data publicly available, the researchers hope to accelerate progress in this important field of medical imaging and cancer treatment.
Technical Explanation
The UCSF-BMSR dataset contains 560 brain MRI scans from 412 patients with brain metastases. The scans include registered and skull-stripped T1 post-contrast, T1 pre-contrast, FLAIR, and subtraction (T1 pre-contrast - T1 post-contrast) images. Voxel-wise segmentations of the brain metastases have been provided, as well as patient demographic information, surgical status, and primary cancer types.
This dataset is designed to support the development of AI models for brain tumor segmentation and other AI applications related to brain metastases. The availability of multimodal MRI data, expert annotations, and associated clinical information makes the UCSF-BMSR dataset a valuable resource for the research community.
Critical Analysis
The UCSF-BMSR dataset provides a comprehensive, high-quality resource for advancing AI research on brain metastases. The inclusion of diverse MRI modalities, detailed annotations, and associated clinical data is a significant strength that sets this dataset apart.
However, the dataset is limited to a specific patient population treated at a single institution. While this allows for consistent data collection and annotation, it may not fully capture the heterogeneity of brain metastases seen in the broader patient population. Additionally, the dataset does not include long-term outcome data, which could be valuable for developing prognostic models or exploring the relationship between imaging features and clinical outcomes.
Future research could explore ways to expand the UCSF-BMSR dataset, such as by incorporating data from other institutions or collecting additional longitudinal data. This would help ensure the broader applicability and generalizability of the research findings.
Conclusion
The UCSF-BMSR dataset is a valuable, publicly available resource for advancing AI research on brain metastases. The dataset's rich collection of multimodal MRI data, expert annotations, and associated clinical information provides a strong foundation for developing innovative brain tumor segmentation and other AI-powered tools to improve the diagnosis, treatment, and care of patients with this challenging condition.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
💬
0
The University of California San Francisco Brain Metastases Stereotactic Radiosurgery (UCSF-BMSR) MRI Dataset
Jeffrey D. Rudie, Rachit Saluja, David A. Weiss, Pierre Nedelec, Evan Calabrese, John B. Colby, Benjamin Laguna, John Mongan, Steve Braunstein, Christopher P. Hess, Andreas M. Rauschecker, Leo P. Sugrue, Javier E. Villanueva-Meyer
The University of California San Francisco Brain Metastases Stereotactic Radiosurgery (UCSF-BMSR) dataset is a public, clinical, multimodal brain MRI dataset consisting of 560 brain MRIs from 412 patients with expert annotations of 5136 brain metastases. Data consists of registered and skull stripped T1 post-contrast, T1 pre-contrast, FLAIR and subtraction (T1 pre-contrast - T1 post-contrast) images and voxelwise segmentations of enhancing brain metastases in NifTI format. The dataset also includes patient demographics, surgical status and primary cancer types. The UCSF-BSMR has been made publicly available in the hopes that researchers will use these data to push the boundaries of AI applications for brain metastases. The dataset is freely available for non-commercial use at https://imagingdatasets.ucsf.edu/dataset/1
Read more6/3/2024
📈
0
The Brain Tumor Segmentation (BraTS-METS) Challenge 2023: Brain Metastasis Segmentation on Pre-treatment MRI
Ahmed W. Moawad, Anastasia Janas, Ujjwal Baid, Divya Ramakrishnan, Rachit Saluja, Nader Ashraf, Leon Jekel, Raisa Amiruddin, Maruf Adewole, Jake Albrecht, Udunna Anazodo, Sanjay Aneja, Syed Muhammad Anwar, Timothy Bergquist, Evan Calabrese, Veronica Chiang, Verena Chung, Gian Marco Marco Conte, Farouk Dako, James Eddy, Ivan Ezhov, Ariana Familiar, Keyvan Farahani, Juan Eugenio Iglesias, Zhifan Jiang, Elaine Johanson, Anahita Fathi Kazerooni, Florian Kofler, Kiril Krantchev, Dominic LaBella, Koen Van Leemput, Hongwei Bran Li, Marius George Linguraru, Katherine E. Link, Xinyang Liu, Nazanin Maleki, Zeke Meier, Bjoern H Menze, Harrison Moy, Klara Osenberg, Marie Piraud, Zachary Reitman, Russel Takeshi Shinohara, Nourel hoda Tahon, Ayman Nada, Yuri S. Velichko, Chunhao Wang, Benedikt Wiestler, Walter Wiggins, Umber Shafique, Klara Willms, Arman Avesta, Khaled Bousabarah, Satrajit Chakrabarty, Nicolo Gennaro, Wolfgang Holler, Manpreet Kaur, Pamela LaMontagne, MingDe Lin, Jan Lost, Daniel S. Marcus, Ryan Maresca, Sarah Merkaj, Ayaman Nada, Gabriel Cassinelli Pedersen, Marc von Reppert, Aristeidis Sotiras, Oleg Teytelboym, Niklas Tillmans, Malte Westerhoff, Ayda Youssef, Devon Godfrey, Scott Floyd, Andreas Rauschecker, Javier Villanueva-Meyer, Irada Pfluger, Jaeyoung Cho, Martin Bendszus, Gianluca Brugnara, Justin Cramer, Gloria J. Guzman Perez-Carillo, Derek R. Johnson, Anthony Kam, Benjamin Yin Ming Kwan, Lillian Lai, Neil U. Lall, Fatima Memon, Satya Narayana Patro, Bojan Petrovic, Tiffany Y. So, Gerard Thompson, Lei Wu, E. Brooke Schrickel, Anu Bansal, Frederik Barkhof, Cristina Besada, Sammy Chu, Jason Druzgal, Alexandru Dusoi, Luciano Farage, Fabricio Feltrin, Amy Fong, Steve H. Fung, R. Ian Gray, Ichiro Ikuta, Michael Iv, Alida A. Postma, Amit Mahajan, David Joyner, Chase Krumpelman, Laurent Letourneau-Guillon, Christie M. Lincoln, Mate E. Maros, Elka Miller, Fanny Mor'on, Esther A. Nimchinsky, Ozkan Ozsarlak, Uresh Patel, Saurabh Rohatgi, Atin Saha, Anousheh Sayah, Eric D. Schwartz, Robert Shih, Mark S. Shiroishi, Juan E. Small, Manoj Tanwar, Jewels Valerie, Brent D. Weinberg, Matthew L. White, Robert Young, Vahe M. Zohrabian, Aynur Azizova, Melanie Maria Theresa Bru{ss}eler, Pascal Fehringer, Mohanad Ghonim, Mohamed Ghonim, Athanasios Gkampenis, Abdullah Okar, Luca Pasquini, Yasaman Sharifi, Gagandeep Singh, Nico Sollmann, Theodora Soumala, Mahsa Taherzadeh, Nikolay Yordanov, Philipp Vollmuth, Martha Foltyn-Dumitru, Ajay Malhotra, Aly H. Abayazeed, Francesco Dellepiane, Philipp Lohmann, V'ictor M. P'erez-Garc'ia, Hesham Elhalawani, Sanaria Al-Rubaiey, Rui Duarte Armindo, Kholod Ashraf, Moamen M. Asla, Mohamed Badawy, Jeroen Bisschop, Nima Broomand Lomer, Jan Bukatz, Jim Chen, Petra Cimflova, Felix Corr, Alexis Crawley, Lisa Deptula, Tasneem Elakhdar, Islam H. Shawali, Shahriar Faghani, Alexandra Frick, Vaibhav Gulati, Muhammad Ammar Haider, F'atima Hierro, Rasmus Holmboe Dahl, Sarah Maria Jacobs, Kuang-chun Jim Hsieh, Sedat G. Kandemirli, Katharina Kersting, Laura Kida, Sofia Kollia, Ioannis Koukoulithras, Xiao Li, Ahmed Abouelatta, Aya Mansour, Ruxandra-Catrinel Maria-Zamfirescu, Marcela Marsiglia, Yohana Sarahi Mateo-Camacho, Mark McArthur, Olivia McDonnell, Maire McHugh, Mana Moassefi, Samah Mostafa Morsi, Alexander Muntenu, Khanak K. Nandolia, Syed Raza Naqvi, Yalda Nikanpour, Mostafa Alnoury, Abdullah Mohamed Aly Nouh, Francesca Pappafava, Markand D. Patel, Samantha Petrucci, Eric Rawie, Scott Raymond, Borna Roohani, Sadeq Sabouhi, Laura M. Sanchez-Garcia, Zoe Shaked, Pokhraj P. Suthar, Talissa Altes, Edvin Isufi, Yaseen Dhermesh, Jaime Gass, Jonathan Thacker, Abdul Rahman Tarabishy, Benjamin Turner, Sebastiano Vacca, George K. Vilanilam, Daniel Warren, David Weiss, Klara Willms, Fikadu Worede, Sara Yousry, Wondwossen Lerebo, Alejandro Aristizabal, Alexandros Karargyris, Hasan Kassem, Sarthak Pati, Micah Sheller, Spyridon Bakas, Jeffrey D. Rudie, Mariam Aboian
The translation of AI-generated brain metastases (BM) segmentation into clinical practice relies heavily on diverse, high-quality annotated medical imaging datasets. The BraTS-METS 2023 challenge has gained momentum for testing and benchmarking algorithms using rigorously annotated internationally compiled real-world datasets. This study presents the results of the segmentation challenge and characterizes the challenging cases that impacted the performance of the winning algorithms. Untreated brain metastases on standard anatomic MRI sequences (T1, T2, FLAIR, T1PG) from eight contributed international datasets were annotated in stepwise method: published UNET algorithms, student, neuroradiologist, final approver neuroradiologist. Segmentations were ranked based on lesion-wise Dice and Hausdorff distance (HD95) scores. False positives (FP) and false negatives (FN) were rigorously penalized, receiving a score of 0 for Dice and a fixed penalty of 374 for HD95. Eight datasets comprising 1303 studies were annotated, with 402 studies (3076 lesions) released on Synapse as publicly available datasets to challenge competitors. Additionally, 31 studies (139 lesions) were held out for validation, and 59 studies (218 lesions) were used for testing. Segmentation accuracy was measured as rank across subjects, with the winning team achieving a LesionWise mean score of 7.9. Common errors among the leading teams included false negatives for small lesions and misregistration of masks in space.The BraTS-METS 2023 challenge successfully curated well-annotated, diverse datasets and identified common errors, facilitating the translation of BM segmentation across varied clinical environments and providing personalized volumetric reports to patients undergoing BM treatment.
Read more6/18/2024
0
BC-MRI-SEG: A Breast Cancer MRI Tumor Segmentation Benchmark
Anthony Bilic, Chen Chen
Binary breast cancer tumor segmentation with Magnetic Resonance Imaging (MRI) data is typically trained and evaluated on private medical data, which makes comparing deep learning approaches difficult. We propose a benchmark (BC-MRI-SEG) for binary breast cancer tumor segmentation based on publicly available MRI datasets. The benchmark consists of four datasets in total, where two datasets are used for supervised training and evaluation, and two are used for zero-shot evaluation. Additionally we compare state-of-the-art (SOTA) approaches on our benchmark and provide an exhaustive list of available public breast cancer MRI datasets. The source code has been made available at https://irulenot.github.io/BC_MRI_SEG_Benchmark.
Read more6/4/2024
0
MSTT-199: MRI Dataset for Musculoskeletal Soft Tissue Tumor Segmentation
Tahsin Reasat, Stephen Chenard, Akhil Rekulapelli, Nicholas Chadwick, Joanna Shechtel, Katherine van Schaik, David S. Smith, Joshua Lawrenz
Accurate musculoskeletal soft tissue tumor segmentation is vital for assessing tumor size, location, diagnosis, and response to treatment, thereby influencing patient outcomes. However, segmentation of these tumors requires clinical expertise, and an automated segmentation model would save valuable time for both clinician and patient. Training an automatic model requires a large dataset of annotated images. In this work, we describe the collection of an MR imaging dataset of 199 musculoskeletal soft tissue tumors from 199 patients. We trained segmentation models on this dataset and then benchmarked them on a publicly available dataset. Our model achieved the state-of-the-art dice score of 0.79 out of the box without any fine tuning, which shows the diversity and utility of our curated dataset. We analyzed the model predictions and found that its performance suffered on fibrous and vascular tumors due to their diverse anatomical location, size, and intensity heterogeneity. The code and models are available in the following github repository, https://github.com/Reasat/mstt
Read more9/6/2024